ArticleBioengineering & translational medicine2022

Long-acting and extended-release implant and nanoformulations with a synergistic antiretroviral two-drug combination controls HIV-1 infection in a humanized mouse model.

Jagadish Beloor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.